1424 related articles for article (PubMed ID: 30979733)
41. Artificial intelligence-based preoperative prediction system for diagnosis and prognosis in epithelial ovarian cancer: A multicenter study.
Wu M; Zhao Y; Dong X; Jin Y; Cheng S; Zhang N; Xu S; Gu S; Wu Y; Yang J; Yao L; Wang Y
Front Oncol; 2022; 12():975703. PubMed ID: 36212430
[TBL] [Abstract][Full Text] [Related]
42. Prediction of pulmonary pressure after Glenn shunts by computed tomography-based machine learning models.
Huang L; Li J; Huang M; Zhuang J; Yuan H; Jia Q; Zeng D; Que L; Xi Y; Lin J; Dong Y
Eur Radiol; 2020 Mar; 30(3):1369-1377. PubMed ID: 31705256
[TBL] [Abstract][Full Text] [Related]
43. Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.
Furrer D; Grégoire J; Turcotte S; Plante M; Bachvarov D; Trudel D; Têtu B; Douville P; Bairati I
PLoS One; 2019; 14(6):e0218621. PubMed ID: 31220149
[TBL] [Abstract][Full Text] [Related]
44. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
45. Machine learning based models for prediction of subtype diagnosis of primary aldosteronism using blood test.
Kaneko H; Umakoshi H; Ogata M; Wada N; Iwahashi N; Fukumoto T; Yokomoto-Umakoshi M; Nakano Y; Matsuda Y; Miyazawa T; Sakamoto R; Ogawa Y
Sci Rep; 2021 May; 11(1):9140. PubMed ID: 33947886
[TBL] [Abstract][Full Text] [Related]
46. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.
Deist TM; Dankers FJWM; Valdes G; Wijsman R; Hsu IC; Oberije C; Lustberg T; van Soest J; Hoebers F; Jochems A; El Naqa I; Wee L; Morin O; Raleigh DR; Bots W; Kaanders JH; Belderbos J; Kwint M; Solberg T; Monshouwer R; Bussink J; Dekker A; Lambin P
Med Phys; 2018 Jul; 45(7):3449-3459. PubMed ID: 29763967
[TBL] [Abstract][Full Text] [Related]
47. Multiparametric ultrasomics of significant liver fibrosis: A machine learning-based analysis.
Li W; Huang Y; Zhuang BW; Liu GJ; Hu HT; Li X; Liang JY; Wang Z; Huang XW; Zhang CQ; Ruan SM; Xie XY; Kuang M; Lu MD; Chen LD; Wang W
Eur Radiol; 2019 Mar; 29(3):1496-1506. PubMed ID: 30178143
[TBL] [Abstract][Full Text] [Related]
48. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
Carbotti G; Orengo AM; Mezzanzanica D; Bagnoli M; Brizzolara A; Emionite L; Puppo A; Centurioni MG; Bruzzone M; Marroni P; Rossello A; Canevari S; Ferrini S; Fabbi M
Int J Cancer; 2013 Jun; 132(11):2597-605. PubMed ID: 23169448
[TBL] [Abstract][Full Text] [Related]
49. Comparison of supervised machine learning classification techniques in prediction of locoregional recurrences in early oral tongue cancer.
Alabi RO; Elmusrati M; Sawazaki-Calone I; Kowalski LP; Haglund C; Coletta RD; Mäkitie AA; Salo T; Almangush A; Leivo I
Int J Med Inform; 2020 Apr; 136():104068. PubMed ID: 31923822
[TBL] [Abstract][Full Text] [Related]
50. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
51. Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer.
Paik ES; Sohn I; Baek SY; Shim M; Choi HJ; Kim TJ; Choi CH; Lee JW; Kim BG; Lee YY; Bae DS
Cancer Res Treat; 2017 Jul; 49(3):635-642. PubMed ID: 27669704
[TBL] [Abstract][Full Text] [Related]
52. Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma.
Hu J; Jiao X; Zhu L; Guo H; Wu Y
BMC Cancer; 2020 Sep; 20(1):938. PubMed ID: 32993522
[TBL] [Abstract][Full Text] [Related]
53. Statistical characterization and classification of colon microarray gene expression data using multiple machine learning paradigms.
Maniruzzaman M; Jahanur Rahman M; Ahammed B; Abedin MM; Suri HS; Biswas M; El-Baz A; Bangeas P; Tsoulfas G; Suri JS
Comput Methods Programs Biomed; 2019 Jul; 176():173-193. PubMed ID: 31200905
[TBL] [Abstract][Full Text] [Related]
54. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
Yang HM; Lou G
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
[No Abstract] [Full Text] [Related]
55. Impact of Preoperative Serum Levels of CA 125 on Epithelial Ovarian Cancer Survival.
Pradjatmo H; Pradjatmo H
Asian Pac J Cancer Prev; 2016; 17(4):1881-6. PubMed ID: 27221870
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.
Yuan L; Wan J; Huang C; Liang J; Liu M; Yue C; Li L
Cancer Biomark; 2017 Dec; 21(1):97-104. PubMed ID: 29036787
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.
Zeng Y; Chen M; Ganesh S; Hu S; Chen H
PLoS One; 2020; 15(5):e0232235. PubMed ID: 32401768
[TBL] [Abstract][Full Text] [Related]
59. Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.
Wu X; Li D; Liu L; Liu B; Liang H; Yang B
Arch Gynecol Obstet; 2014 Jun; 289(6):1309-14. PubMed ID: 24370956
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125.
Jin C; Yang M; Han X; Chu H; Zhang Y; Lu M; Wang Z; Xu X; Liu W; Wang F; Ju S
J Ovarian Res; 2019 Nov; 12(1):114. PubMed ID: 31767040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
